©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 110840
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.110840
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.110840
Figure 5 National or regional intervention timeline of preventing viral hepatitis and hepatocellular carcinoma in Taiwan, Poland, Flanders.
HBeAg: Hepatitis B e antigen; HBIG: Hepatitis B immune globulin; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus; HCV: Hepatitis C virus; HIV: Human immunodeficiency virus.
- Citation: Huang ZZ, Żmudka K, Ruggiano V, Hsu WL, Liu J, Chiang CJ, Chen YC, Wang V. Secular trend in universal hepatocellular carcinoma prevention: Taiwan, Poland, and Belgium experience. World J Gastrointest Oncol 2025; 17(11): 110840
- URL: https://www.wjgnet.com/1948-5204/full/v17/i11/110840.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.110840